LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $219 | -17.0% | 3,658 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $264 | -99.9% | 3,658 | +15.8% | 0.00% | -50.0% |
| Q2 2022 | $282,000 | -20.6% | 3,158 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $355,000 | -27.3% | 3,158 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $488,000 | +37.1% | 3,158 | +23.5% | 0.00% | 0.0% |
| Q3 2021 | $356,000 | +6.0% | 2,558 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $336,000 | -6.4% | 2,558 | +8.5% | 0.00% | 0.0% |
| Q1 2021 | $359,000 | -6.5% | 2,358 | -38.9% | 0.00% | 0.0% |
| Q4 2020 | $384,000 | +4.3% | 3,858 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $368,000 | -57.4% | 3,858 | -50.0% | 0.00% | -25.0% |
| Q2 2020 | $864,000 | – | 7,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |